FDA Inspection 1177994 — National Cancer Institute Central IRB

National Cancer Institute Central IRB — FEI 3011142166

The FDA completed an inspection of National Cancer Institute Central IRB on Aug 9, 2022 in Rockville, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.